ARS Pharmaceuticals, Inc. - Common Stock —— 季度现金流量表 (NASDAQ:SPRY) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 351.15 M327.32 M313.47 M372.8 M327.65 M287.57 M 负债总额 94.36 M98.34 M121.15 M225.15 M213.39 M226.26 M 权益总额 256.8 M228.97 M192.32 M147.66 M114.26 M61.31 M 负债及股东权益总额 351.15 M327.32 M313.47 M372.8 M327.65 M287.57 M 总债务 —————— 净债务 ——————

新闻

ARS Pharmaceuticals, Inc. (SPRY) Q1 2026 Earnings Call Transcript

ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Beats Revenue Estimates

ARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most A

Eton Pharmaceuticals, Inc. (ETON) Misses Q1 Earnings Estimates

Merck KGaA (MKKGY) Surpasses Q1 Earnings and Revenue Estimates

Cronos Group (CRON) Q1 Earnings Meet Estimates

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Beat Estimates

Earnings Preview: ARS Pharmaceuticals, Inc. (SPRY) Q1 Earnings Expected to Decline

ARS Pharmaceuticals, Inc. (SPRY) Soars 7.1%: Is Further Upside Left in the Stock?

ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines (SPRY)

Leerink上调ARS Pharmaceuticals目标价,看好销售扩张

Leerink raises ARS Pharmaceuticals stock price target on sales expansion